BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6417683)

  • 1. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
    Kunze H; Bohn E; Damerau B
    Pharmacol Res Commun; 1983 Oct; 15(9):869-78. PubMed ID: 6417683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes.
    Kunze H; Bohn E
    Pharmacol Res Commun; 1983 May; 15(5):451-9. PubMed ID: 6412250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
    Hesse B; Lankisch PG; Kunze H
    Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
    Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
    Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J; Magerstedt P; Schmid K
    Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
    Freise J; Wittenberg H; Magerstedt P
    Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes.
    Damerau B; Wüstefeld H; Fricke D; Kunze H
    Agents Actions; 1984 Dec; 15(5-6):594-9. PubMed ID: 6442538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR; Büchler M; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiinflammatory activity of analogs of indomethacin correlates with their inhibitory effects on phospholipase A2 of rabbit polymorphonuclear leukocytes.
    Kaplan-Harris L; Elsbach P
    Biochim Biophys Acta; 1980 May; 618(2):318-26. PubMed ID: 7378442
    [No Abstract]   [Full Text] [Related]  

  • 10. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lysosomal phospholipases C and A in rabbit alveolar macrophages, polymorphonuclear leukocytes and rat liver by sodium bisulfite.
    Eisen D; Bartolf M; Franson RC
    Biochim Biophys Acta; 1984 Mar; 793(1):10-7. PubMed ID: 6704407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of an inflammatory exudate phospholipase A2 by an endogenous inhibitor of polymorphonuclear leucocytes.
    Authi KS; Solanky A; Traynor JR
    Pharmacol Res Commun; 1982 May; 14(5):401-7. PubMed ID: 7111357
    [No Abstract]   [Full Text] [Related]  

  • 13. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.
    Hirata F; Schiffmann E; Venkatasubramanian K; Salomon D; Axelrod J
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2533-6. PubMed ID: 6930649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J
    Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes.
    Kaplan L; Weiss J; Elsbach P
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2955-8. PubMed ID: 275865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
    Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
    Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ions.
    Franson RC; Eisen D; Jesse R; Lanni C
    Biochem J; 1980 Feb; 186(2):633-6. PubMed ID: 7378071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the incorporation of [1-14C]arachidonic acid into glycerolipids and its conversion into prostaglandins by rabbit iris. Effects of anti-inflammatory drugs and phospholipase A2 inhibitors.
    Abdel-Latif AA; Smith JP
    Biochim Biophys Acta; 1982 Jun; 711(3):478-89. PubMed ID: 6809058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes.
    Märki F; Franson R
    Biochim Biophys Acta; 1986 Nov; 879(2):149-56. PubMed ID: 3768394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.